<DOC>
	<DOC>NCT02591992</DOC>
	<brief_summary>To evaluate the safety and effectiveness of computed tomography angiography in the diagnostic and therapeutic cycle as the first-choice method of imaging in the diagnosis of patients with a high probability of stable coronary artery disease according to European Society of Cardiology recommendations.</brief_summary>
	<brief_title>Computed Tomography as the First-Choice Diagnostics in High Pre-Test Probability of Coronary Artery Disease</brief_title>
	<detailed_description>A prospective, randomized open-label, single center trial to evaluate superiority of angio-CT to a classic coronary angiography (concerning effectiveness and safety) in the diagnosis of stable coronary artery disease in patients with indications for invasive coronary angiography.</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>1. Age &gt;18 years 2. Patients providing written informed consent 3. Indications for elective invasive coronary angiography defined by European Society of Cardiology as: Left ventricle ejection fraction &lt;50% and typical angina symptoms, Probability of coronary artery disease due to criteria of age, sex and symptoms &gt;85%, or Probability of coronary artery disease due to criteria of age, sex and symptoms 5085% with positive or moderate cardiac stress test. 1. No Consent to the study 2. Acute coronary syndrome 3. Recurrence of typical angina symptoms 1 year after the last percutaneous coronary revascularization, 4. Contraindications to invasive coronary angiography 5. GFR &lt;60 ml/min/1.73m2 6. Significant arrhythmia 7. BMI &gt;35 kg/m2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>